Aptar CSP Technologies Expands Offerings with cGMP Early-Stage Clinical Manufacturing Site for Tablet and Capsule-Based Drug Products

New site accelerates implementation of Activ-Blister technology for mitigating degradation and impurities risk, including nitrosamine formation.

Csp New Jersey Blister Line

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Aptar CSP Technologies, part of AptarGroup, Inc. and a global expert in active material science solutions, announced the expansion of its service offerings with the launch of a cGMP-compliant manufacturing facility in New Jersey. The new site will support clinical packaging for oral solid dose (OSD) and capsule-based DPI drugs utilizing Aptar CSP’s proprietary Activ-Polymer platform and Activ-Blister solutions.

The expansion addresses growing market demand for enhanced drug stability and nitrosamine risk mitigation. Aptar CSP’s Activ-Blister technology integrates a highly engineered active film material into thermoform and cold-form blister packaging configurations, creating a microclimate that protects individual doses from moisture, oxygen, VOCs, and degradation, including reducing the risk of N-nitrosamine formation. The technology delivers customizable, dose-specific protection tailored to the unique stability needs of each drug formulation.

“Launching this cGMP facility reinforces our commitment to delivering streamlined access to innovative active material science technologies for patients and pharmaceutical partners,” said Badre Hammond, Vice President Commercial Operations and General Manager, Aptar CSP Technologies. “By offering early-stage clinical services with custom-designed equipment, we simplify adoption, eliminate implementation barriers, and help avoid lengthy reformulation or repackaging efforts.”

The new site, which is the result of a collaboration with MOD3 Pharma, will offer services including R&D support, Phase I and II clinical material manufacturing, full CMC package (Chemistry, Manufacturing, and Controls), stability studies, and clinical supply management.

Aptar CSP’s 3-Phase Activ-Polymer platform technology is trusted worldwide to protect high-value products such as drugs, diagnostics, probiotics, medical devices, and implants.

Fill out the form below to request more information about Aptar CSP Technologies Expands Offerings with cGMP Early-Stage Clinical Manufacturing Site for Tablet and Capsule-Based Drug Products
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences